Metallothionein-1 (MT1) is usually downregulated in CRC, so its upregulation as a result of 5-fluorouracil treatment could result in improved survival rates in colorectal cancer, potentially due to its role in promoting cancer cell differentiation (Arriaga et al., 2017). This evidence concerns the gene MT1A and colorectal cancer.